These results suggest that, while lacking prognostic value in the whole and heterogeneous population of bladder cancer patients, both the HOTAIR rs920778 and rs12826786 genetic variants exhibit significant implications for the outcomes of specific subgroups of patients, stratified according to clinically relevant variables like age, sex, and tumor stages. This evidence concerns the gene HOTAIR and urinary bladder carcinoma.